SCHEMBL1249758

SCHEMBL1249758

NO[C@H]1C[C@H](C(=O)O)N(C(=O)O)C1

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.39
AGTR2 P50052 8/20 0.33
FOLH1 Q04609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1249753 1.00 ATM (0.39) ATMAGTR2FOLH1
SCHEMBL1249755 1.00 ATM (0.39) ATMAGTR2FOLH1
SCHEMBL3405107 0.82 MMP2 (0.49)
SCHEMBL13745872 0.82 MMP2 (0.49)
SCHEMBL3440720 0.81 ATM (0.43) ATMAGTR2
SCHEMBL19064872 0.81 ATM (0.43) ATMAGTR2
SCHEMBL29253522 0.81 ATM (0.43) ATMAGTR2
SCHEMBL6596413 0.81 ATM (0.43) ATMAGTR2
SCHEMBL5160994 0.81 ATM (0.43) ATMAGTR2
SCHEMBL2770048 0.81 ATM (0.43) ATMAGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2279737-B1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2012-10-31 EP disclosed
EP-2279737-A1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2011-02-02 EP disclosed
EP-1480644-B1 NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES NOVEXEL (FR) 2010-10-13 EP disclosed
EP-1307457-B1 AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE AS MEDICINES, IN PARTICULAR AS ANTIBACTERIAL AGENTS AVENTIS PHARMA SA (FR) 2004-04-07 EP disclosed